质子泵抑制剂对血糖控制及新发糖尿病风险的影响:系统综述与荟萃分析
该系统综述与荟萃分析评估了质子泵抑制剂(PPI)对糖尿病患者血糖控制及非糖尿病人群新发糖尿病风险的影响。结果显示,在标准治疗基础上加用PPI可显著降低糖化血红蛋白(HbA1c)和空腹血糖(FBG),但并未降低新发糖尿病的风险。
要点
- 在标准治疗基础上加用PPI可显著降低糖尿病患者的HbA1c和空腹血糖。
- PPI使用并未降低非糖尿病人群新发糖尿病的风险。
- 为糖尿病患者处方抑酸药时,应考虑PPI对血糖控制的影响。
核心结论
- 在标准治疗基础上加用PPI可改善糖尿病患者的血糖指标,但并未改变新发糖尿病的风险。
研究设计与样本
- 采用随机效应模型计算加权均数差(WMD)或相对风险(RR)。
主要发现
- 与标准治疗相比,加用PPI与HbA1c显著下降相关(WMD -0.36%;95% CI -0.68至-0.05;P=0.025)。
- 加用PPI与空腹血糖显著下降相关(WMD -10.0 mg/dL;95% CI -19.4至-0.6;P=0.037)。
- PPI使用未降低新发糖尿病风险(合并RR 1.10;95% CI 0.89至1.34;P=0.385)。
临床怎么用
- 为糖尿病患者处方抑酸药时,应考虑PPI对血糖控制的潜在影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Whether proton pump inhibitors (PPI) can improve glycemic control among individuals with diabetes or decrease the risk of incident diabetes in the general population is unclear. OBJECTIVE: To evaluate the impact of PPI therapy on glycemic control among individuals with diabetes and the risk of diabetes among those without diabetes. RESULTS: PubMed, Embase, Scopus, and ClinicalTrials.gov were searched from inception to November 21, 2020. We included studies comparing glycosylated hemoglobin (HbA1c) or fasting blood glucose (FBG) among individuals with diabetes treated with and without PPI therapy as an add-on to standard therapy. Studies evaluating the risk of incident diabetes among individuals taking PPI were assessed. We performed dual independent review, data extraction, and quality assessment. Weighted mean differences between groups or relative risks were imputed using random-effects models. RESULTS: Seven studies (n = 342) for glycemic control and 5 studies (n = 244 439) for risk of incident diabetes were included. Compared with standard therapy, add-on PPI was associated with a significant decrease in HbA1c (WMD, -0.36 %; 95% CI, -0.68 to -0.05; P = 0.025) and FBG (WMD, -10.0 mg/dL; 95% CI, -19.4 to -0.6; P = 0.037). PPI use did not reduce the risk of incident diabetes (pooled RR, 1.10; 95% CI, 0.89 to 1.34; P = 0.385). CONCLUSION: Add-on PPI improved glycemic indices among individuals with diabetes but did not alter the risk of incident diabetes. The effects of PPI on glycemic control should be considered when prescribing antacids to patients with diabetes.
引用
- Peng CC, Tu YK, Lee GY, et al. Effects of Proton Pump Inhibitors on Glycemic Control and Incident Diabetes: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab. 2021. PMID: 34170301. doi:10.1210/clinem/dgab353
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。